abstract |
The present invention relates to the delivery of binding molecules such as antibodies, antibody fragments, single antibody variable domains, soluble receptors, ligands and dominant negative mutants to induce immune modulation in patients. More specifically, the present invention relates to the production of a medicament comprising said binding molecule producing microorganism and the use of this medicament in the treatment of immune mediated diseases. |